Diving Deep into Immune Checkpoint Inhibitors
This deep dive focuses on the value of ePROs in managing immune-related adverse effects and the impact this has on patient wellbeing and outcomes. It also considers the value and potential of the real-world data collected within the context of patients’ environments, and how this longitudinal view of patient wellbeing and treatment progression gives pharma companies a competitive advantage within the market.
Thank you! This deep dive is ready to download.
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.Download PDF
Oops! Something went wrong while submitting the form.
you may also like